Combined adjuvants of poly(I:C) plus LAG-3-Ig improve antitumor effects of tumor-specific T cells, preventing their exhaustion.
about
Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study.Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.Are peptide vaccines viable in combination with other cancer immunotherapies?Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responses.Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 MastocytomaCurrent status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy.
P2860
Combined adjuvants of poly(I:C) plus LAG-3-Ig improve antitumor effects of tumor-specific T cells, preventing their exhaustion.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Combined adjuvants of poly(I:C ...... , preventing their exhaustion.
@ast
Combined adjuvants of poly(I:C ...... , preventing their exhaustion.
@en
type
label
Combined adjuvants of poly(I:C ...... , preventing their exhaustion.
@ast
Combined adjuvants of poly(I:C ...... , preventing their exhaustion.
@en
prefLabel
Combined adjuvants of poly(I:C ...... , preventing their exhaustion.
@ast
Combined adjuvants of poly(I:C ...... , preventing their exhaustion.
@en
P2093
P2860
P356
P1433
P1476
Combined adjuvants of poly(I:C ...... , preventing their exhaustion.
@en
P2093
Hiroaki Nagano
Hiroto Matsui
Keishi Adachi
Koji Tamada
Shoichi Hazama
Takahiro Iguchi
Tomoya Miyakawa
Yoshiya Ueyama
Yosuke Kano
P2860
P304
P356
10.1111/CAS.12861
P577
2016-04-01T00:00:00Z